| Title |
The Impact of Rotavirus Vaccination on Discounted Net Tax Revenue in Egypt
|
|---|---|
| Published in |
PharmacoEconomics, December 2012
|
| DOI | 10.2165/11597750-000000000-00000 |
| Pubmed ID | |
| Authors |
Mark P. Connolly, Oleksandr Topachevskyi, Baudouin Standaert, Omayra Ortega, Maarten Postma |
| Abstract |
We evaluated national rotavirus (RV) immunization programme costs to estimate how resulting changes in morbidity and mortality will influence government fiscal accounts over time. The assumption was that increased childhood survival in vaccinated cohorts leads to increased numbers of children consuming government resource, and an increased number of future tax payers. |
Mendeley readers
The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Peru | 1 | 2% |
| Unknown | 63 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 15 | 23% |
| Researcher | 12 | 19% |
| Student > Ph. D. Student | 11 | 17% |
| Other | 5 | 8% |
| Student > Bachelor | 4 | 6% |
| Other | 5 | 8% |
| Unknown | 12 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 21 | 33% |
| Economics, Econometrics and Finance | 7 | 11% |
| Nursing and Health Professions | 6 | 9% |
| Social Sciences | 5 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 6% |
| Other | 9 | 14% |
| Unknown | 12 | 19% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 January 2017.
All research outputs
#8,535,684
of 25,374,917 outputs
Outputs from PharmacoEconomics
#996
of 1,992 outputs
Outputs of similar age
#88,136
of 289,102 outputs
Outputs of similar age from PharmacoEconomics
#95
of 280 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,992 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one is in the 25th percentile – i.e., 25% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 289,102 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 280 others from the same source and published within six weeks on either side of this one. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.